Activation/NN
of/IN
JAK3/NN
,/,
but/CC
not/RB
JAK1/NN
,/,
is/VBZ
critical/JJ
for/IN
IL-2-induced/JJ
proliferation/NN
and/CC
STAT5/NN
recruitment/NN
by/IN
a/DT
COOH-terminal/JJ
region/NN
of/IN
the/DT
IL-2/NN
receptor/NN
beta-chain/NN
./.

A/DT
number/NN
of/IN
cytokines/NNS
and/CC
growth/NN
factors/NNS
use/VBP
the/DT
JAK-STAT/NN
pathway/NN
to/TO
signal/VB
from/IN
the/DT
cell/NN
membrane/NN
to/TO
the/DT
nucleus/NN
./.
=====
While/IN
homodimerizing/VBG
cytokine/NN
receptors/NNS
may/MD
transmit/VB
signal/NN
via/IN
a/DT
single/JJ
form/NN
of/IN
JAK/NN
(/(
i.e./FW
growth/NN
hormone/NN
receptors/NNS
)/)
,/,
several/JJ
multicomponent/JJ
cytokine/NN
receptors/NNS
have/VBP
been/VBN
shown/VBN
to/TO
require/VB
simultaneous/JJ
activation/NN
of/IN
pairs/NNS
of/IN
different/JJ
JAK/NN
kinases/NNS
(/(
i.e./FW
interferon/NN
receptors/NNS
)/)
./.
=====
Recent/JJ
evidence/NN
for/IN
a/DT
preferential/JJ
coupling/NN
of/IN
JAK3/NN
to/TO
interleukin-2/NN
receptor-gamma/NN
(/(
IL-2R/NN
gamma/NN
)/)
and/CC
JAK1/NN
to/TO
IL-2R/NN
beta/NN
supports/VBZ
the/DT
concept/NN
of/IN
heterotrans-activation/NN
of/IN
JAK1/NN
and/CC
JAK3/NN
caused/VBN
by/IN
IL-2-induced/JJ
heterodimerization/NN
of/IN
their/PRP$
receptor/NN
partners/NNS
./.
=====
The/DT
present/JJ
study/NN
verified/VBD
the/DT
ability/NN
of/IN
IL-2/NN
to/TO
cause/VB
tyrosine/NN
phosphorylation/NN
and/CC
activation/NN
of/IN
JAK1/NN
and/CC
JAK3/NN
,/,
but/CC
demonstrated/VBD
that/IN
IL-2/NN
stimulated/VBD
JAK3/NN
to/TO
a/DT
significantly/RB
larger/JJR
extent/NN
than/IN
JAK1/NN
in/IN
human/JJ
T/NN
lymphocytes/NNS
and/CC
the/DT
YT/NN
cell/NN
line/NN
./.
=====
This/DT
conclusion/NN
was/VBD
based/VBN
upon/IN
several/JJ
independent/JJ
criteria/NNS
,/,
including/VBG
more/RBR
vigorous/JJ
tyrosine/NN
phosphorylation/NN
of/IN
JAK3/NN
,/,
more/RBR
marked/JJ
enzymatic/JJ
activation/NN
of/IN
JAK3/NN
as/RB
well/RB
as/IN
higher/JJR
abundance/NN
of/IN
JAK3/NN
in/IN
activated/VBN
IL-2/NN
receptor/NN
complexes/NNS
./.
=====
Furthermore/RB
,/,
when/WRB
human/JJ
IL-2R/NN
beta/NN
was/VBD
stably/RB
expressed/VBN
in/IN
murine/JJ
BA/F3/NN
cells/NNS
,/,
robust/JJ
IL-2-induced/JJ
proliferation/NN
and/CC
JAK3/NN
activation/NN
occurred/VBD
without/IN
detectable/JJ
involvement/NN
of/IN
either/CC
JAK1/NN
,/,
JAK2/NN
or/CC
TYK2/NN
./.
=====
We/PRP
therefore/RB
propose/VBP
that/IN
IL-2/NN
receptor/NN
signal/NN
transduction/NN
does/VBZ
not/RB
depend/VB
on/IN
equimolar/JJ
heterodimerization/NN
of/IN
JAK1/NN
and/CC
JAK3/NN
following/VBG
IL-2-induced/JJ
heterodimerization/NN
of/IN
IL-2R/NN
beta/NN
and/CC
IL-2R/NN
gamma/NN
./.
=====
Nonetheless/RB
,/,
a/DT
membrane-proximal/JJ
region/NN
of/IN
human/JJ
IL-2R/NN
beta/NN
(/(
Asn240-Leu335/NN
)/)
was/VBD
critical/JJ
for/IN
JAK3/NN
activation/NN
,/,
and/CC
the/DT
amount/NN
of/IN
JAK3/NN
present/JJ
in/IN
activated/VBN
IL-2/NN
receptor/NN
complexes/NNS
increased/VBD
with/IN
time/NN
,/,
suggesting/VBG
that/IN
stabilization/NN
of/IN
JAK3/NN
binding/NN
to/TO
the/DT
receptor/NN
complex/NN
relies/VBZ
on/IN
both/CC
IL-2R/NN
beta/NN
and/CC
IL-2R/NN
gamma/NN
./.
=====
Moreover/RB
,/,
STAT5/NN
was/VBD
found/VBN
to/TO
be/VB
the/DT
predominant/JJ
STAT/NN
transcription/NN
factor/NN
used/VBN
by/IN
IL-2/NN
in/IN
human/JJ
T/NN
cells/NNS
,/,
and/CC
specifically/RB
required/VBD
a/DT
COOH-terminal/JJ
region/NN
of/IN
IL-2R/NN
beta/NN
(/(
Ser386-Val525/NN
)/)
,/,
while/IN
STAT5/NN
recruitment/NN
was/VBD
not/RB
correlated/VBN
to/TO
activation/NN
of/IN
IL-2R/NN
gamma/NN
or/CC
JAK3/NN
./.